These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23370932)

  • 1. Stability of dilute oral morphine solution for neonatal abstinence syndrome.
    Sauberan J; Rossi S; Kim JH
    J Addict Med; 2013; 7(2):113-5. PubMed ID: 23370932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome.
    Kokotajlo S; Robinson CA; Presti A
    J Opioid Manag; 2013; 9(1):62-70. PubMed ID: 23709305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a paediatric oral formulation of clonidine hydrochloride.
    de Goede AL; Boedhram RR; Eckhardt M; Hanff LM; Koch BC; Vermaat CH; Vermes A
    Int J Pharm; 2012 Aug; 433(1-2):119-20. PubMed ID: 22580108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the stability of morphine sulphate in combination with Instillagel.
    Abdelmageed R; Labyad N; Watson DG; Pournamdari M; Cable CG; Stanley E
    J Clin Pharm Ther; 2008 Jun; 33(3):263-71. PubMed ID: 18452413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
    Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
    Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development and stability testing of oral morphine solution utilizing preformulation approach.
    Preechagoon D; Sumyai V; Tontisirin K; Aumpon S; Pongjanyakul T
    J Pharm Pharm Sci; 2005 Aug; 8(2):362-9. PubMed ID: 16124948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium.
    Liu T; Lewis T; Gauda E; Gobburu J; Ivaturi V
    J Clin Pharmacol; 2016 Aug; 56(8):1009-18. PubMed ID: 26712409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of atenolol in an extemporaneously compounded oral liquid.
    Garner SS; Wiest DB; Reynolds ER
    Am J Hosp Pharm; 1994 Feb; 51(4):508-11. PubMed ID: 8017418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial.
    André P; Cisternino S; Chiadmi F; Toledano A; Schlatter J; Fain O; Fontan JE
    Ann Pharmacother; 2005 Sep; 39(9):1462-6. PubMed ID: 15985470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and chemical stability of pemetrexed in infusion solutions.
    Zhang Y; Trissel LA
    Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of oral liquid preparations of methylergometrine.
    Marigny K; Lohezic-Ledevehat F; Aubin F; Burgot G
    Pharmazie; 2006 Aug; 61(8):701-5. PubMed ID: 16964714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of fluconazole in an extemporaneously prepared oral liquid.
    Yamreudeewong W; Lopez-Anaya A; Rappaport H
    Am J Hosp Pharm; 1993 Nov; 50(11):2366-7. PubMed ID: 8266965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution.
    Tannous E; Tal Y; Amarny K
    Int J Pharm Compd; 2016; 20(5):438-439. PubMed ID: 28339380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags.
    Kaushal G; Sayre BE; Prettyman T
    Drug Discov Ther; 2012 Feb; 6(1):49-54. PubMed ID: 22460429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical analysis of freshly prepared and stored capsaicin solutions: implications for tussigenic challenges.
    Kopec SE; DeBellis RJ; Irwin RS
    Pulm Pharmacol Ther; 2002; 15(6):529-34. PubMed ID: 12493340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.